(Q38148743)

29 August 2017

title

High-throughput methods for combinatorial drug discovery (English)

1 reference

29 August 2017

1 reference

Nicholas P. Tatonetti

object named as

Nicholas P Tatonetti

series ordinal

3

0 references

author name string

Xiaochen Sun

series ordinal

1

1 reference

29 August 2017

Santiago Vilar

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 October 2013

1 reference

Science Translational Medicine

29 August 2017

published in

1 reference

29 August 2017

volume

5

1 reference

29 August 2017

issue

205

1 reference

29 August 2017

page(s)

205rv1

1 reference

Drug repositioning: identifying and developing new uses for existing drugs

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Can the pharmaceutical industry reduce attrition rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Multicomponent therapeutics for networked systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Where is the evidence that animal research benefits humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Can animal models of disease reliably inform human studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Relating protein pharmacology by ligand chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Systematic identification of proteins that elicit drug side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Data-driven prediction of drug effects and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

High-order combination effects and biological robustness

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Diverse types of genetic variation converge on functional gene networks involved in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Gene prioritization in Type 2 Diabetes using domain interactions and network analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

The use of network analyses for elucidating mechanisms in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Discovery and preclinical validation of drug indications using compendia of public gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Pathway analysis of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Network analysis of human in-stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Variations in DNA elucidate molecular networks that cause disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Systems biology and combination therapy in the quest for clinical efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Systematic discovery of multicomponent therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Systematic identification of synergistic drug pairs targeting HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Search algorithms as a framework for the optimization of drug combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Dual targeting of the Akt/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Neighbor communities in drug combination networks characterize synergistic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Chemogenomic profiling predicts antifungal synergies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

A whole-cell computational model predicts phenotype from genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Predicting and characterizing selective multiple drug treatments for metabolic diseases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

An enhanced Petri-net model to predict synergistic effects of pairwise drug combinations from gene microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Pharmacovigilance in the 21st century: new systematic tools for an old problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

ExPASy: SIB bioinformatics resource portal

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006667

10.1126/SCITRANSLMED.3006667

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference